Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Growth (Status and Outlook) 2024-2030

Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Growth (Status and Outlook) 2024-2030

Percutaneous coronary intervention (PCI) refers to the treatment method of using cardiac catheterization techniques to clear narrow or even occluded coronary artery lumens, thereby improving myocardial blood flow perfusion. PCI instruments can be divided into two categories: interventional therapy instruments and coronary pathway assistive instruments. Interventional treatment instruments mainly include stents and balloon catheters, and auxiliary instruments include angiography auxiliary instruments (such as angiography guide wires, angiography catheters, puncture needles, catheter sheath sets, ring handle injectors, arterial compression tourniquets, pressure extension tubes, and three-way cocks) and treatment auxiliary instruments (such as balloon dilation pressure pumps, guide catheters, microwires, Y-connectors, and microcatheters).

The global Percutaneous Coronary Intervention (PCI) Treatment Instruments market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “Percutaneous Coronary Intervention (PCI) Treatment Instruments Industry Forecast” looks at past sales and reviews total world Percutaneous Coronary Intervention (PCI) Treatment Instruments sales in 2022, providing a comprehensive analysis by region and market sector of projected Percutaneous Coronary Intervention (PCI) Treatment Instruments sales for 2023 through 2029. With Percutaneous Coronary Intervention (PCI) Treatment Instruments sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Percutaneous Coronary Intervention (PCI) Treatment Instruments industry.

This Insight Report provides a comprehensive analysis of the global Percutaneous Coronary Intervention (PCI) Treatment Instruments landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Percutaneous Coronary Intervention (PCI) Treatment Instruments portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Percutaneous Coronary Intervention (PCI) Treatment Instruments market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Percutaneous Coronary Intervention (PCI) Treatment Instruments and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Percutaneous Coronary Intervention (PCI) Treatment Instruments.

United States market for Percutaneous Coronary Intervention (PCI) Treatment Instruments is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Percutaneous Coronary Intervention (PCI) Treatment Instruments is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Percutaneous Coronary Intervention (PCI) Treatment Instruments is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Percutaneous Coronary Intervention (PCI) Treatment Instruments players cover Medtronic, Terumo Corporation, Boston Scientific, Cordis, Abbott, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Percutaneous Coronary Intervention (PCI) Treatment Instruments market by product type, application, key players and key regions and countries.

Segmentation by Type:
Interventional Treatment Instruments
Coronary Pathway Assistive Instruments

Segmentation by Application:
Hospital
Clinic
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Interventional Treatment Instruments
Coronary Pathway Assistive Instruments

Segmentation by Application:
Hospital
Clinic
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Medtronic
Terumo Corporation
Boston Scientific
Cordis
Abbott
Merit Medical
QualiMe
Cardionovum
Curatia Medical
ASAHI INTECC
MicroPort Scientific Corporation
Lepu Medical Technology
Shanghai INT Medical Instruments
BrosMed Medical
OrbusNeich Medical Company
Shunmei Medical
Suzhou Innomed Medical Device
APT Medical
Zhejiang Barty Medical Technology
Shenzhen MicroApproach Medical Technology
Beijing Demax Medical Technology
JW Medical Systems
SINOMED
Kinhely Bio-Tech
Shandong Huaan Biotechnology
Blue Sail Medical
Shanghai Bio-heart Biological Technology

Please note: The report will take approximately 2 business days to prepare and deliver.